News
Merck Animal Health has received conditional approval from the U.S. Food and Drug Administration (FDA) for EXZOLT CATTLE-CA1. This is a pour-on solution used for the prevention and treatment of infections caused by New World screwworm larvae in cattle. The drug will be available by prescription in the first quarter of 2026
Source: Wallstreetcn The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments